Akebia Therapeutics (AKBA) Non-Current Assets (2013 - 2026)
Akebia Therapeutics (AKBA) recorded Non-Current Assets of $120.11 million in Q2 2026, up 8.3% from $110.94 million a year earlier and up 0.9% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Akebia Therapeutics reported Non-Current Assets of $123.61 million, up 15.7% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of -14.6% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $106.84 million in FY2024 (-13.5%), $123.55 million in FY2023 (-27.7%), $170.87 million in FY2022 (-33.8%) and $258.2 million in FY2021 (-5.3%).
- Quarterly Non-Current Assets has ranged from $105.82 million in Q3 2025 to $272.18 million in Q3 2021 over the past five years.
- On a year-over-year basis, Non-Current Assets has increased for three consecutive quarters, with growth averaging 0.5% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 15.7% in Q4 2025, against a decline of 39.0% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $119.04 million (Q1 2026), $123.61 million (Q4 2025) and $105.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn | 120.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 120.11 Mn |
| Mar 31, 2026 | 119.04 Mn |
| Dec 31, 2025 | 123.61 Mn |
| Sep 30, 2025 | 105.82 Mn |
| Jun 30, 2025 | 110.94 Mn |
| Mar 31, 2025 | 106.40 Mn |
| Dec 31, 2024 | 106.84 Mn |
| Sep 30, 2024 | 107.02 Mn |
| Jun 30, 2024 | 108.10 Mn |
| Mar 31, 2024 | 112.53 Mn |
| Dec 31, 2023 | 123.55 Mn |
| Sep 30, 2023 | 125.40 Mn |
| Jun 30, 2023 | 135.27 Mn |
| Mar 31, 2023 | 160.13 Mn |
| Dec 31, 2022 | 170.87 Mn |
| Sep 30, 2022 | 202.04 Mn |
| Jun 30, 2022 | 221.63 Mn |
| Mar 31, 2022 | 236.66 Mn |
| Dec 31, 2021 | 258.20 Mn |
| Sep 30, 2021 | 272.18 Mn |
API Access
Akebia Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();